Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genito-Urinary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05629065
What this trial is testing

Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)

Who this might be right for
Breast CancerGastrointestinal CancerGynecologic Cancer+2 more
Dana-Farber Cancer Institute 800
Not applicableStudy completedNCT01278537
What this trial is testing

Patient Empowerment and Risk-assessed Treatment to Improve Outcome in the Elderly After Onco-surgery

Who this might be right for
Cancer
Charite University, Berlin, Germany 690
Not applicableLooking for participantsNCT06795087
What this trial is testing

Discharge Medication Use Post-Operatively in GU Cancer Patients

Who this might be right for
Genitourinary Cancer
Wake Forest University Health Sciences 684
Not applicableEnded earlyNCT03134027
What this trial is testing

Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) Cancers

Who this might be right for
Genito Urinary CancerBladder CancerKidney Cancer+1 more
Duke University 3
Not applicableLooking for participantsNCT04923178
What this trial is testing

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

Who this might be right for
Urothelial CancerBladder CancerGenitourinary Cancer+2 more
National Cancer Institute (NCI) 1,100
Not applicableEnded earlyNCT00147238
What this trial is testing

A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast

Who this might be right for
Bladder CancerGenitourinary CancerProstate Cancer
M.D. Anderson Cancer Center 10
Not applicableLooking for participantsNCT02906943
What this trial is testing

Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

Who this might be right for
Breast CancerLung CancerColorectal Cancer+8 more
University Health Network, Toronto 10,000
Not applicableLooking for participantsNCT05300308
What this trial is testing

Lymphoedema and Nocturia/Nocturnal Polyuria After Pelvic LND for Urogenital Cancer

Who this might be right for
Urogenital CancerLower Limb LymphedemaNocturia+1 more
Universitaire Ziekenhuizen KU Leuven 150
Not applicableUnknownNCT05421377
What this trial is testing

Development of a Clinical Screening, Diagnostic and Evaluation Tool for Patients With Lower Limb Lymphedema: Aim 2

Who this might be right for
Lower Limb Lymphedema
KU Leuven 120
Not applicableWithdrawnNCT03238053
What this trial is testing

Laser Treatment of Genito-urinary Syndrome in Women

Who this might be right for
Laser-Induced ScarBreast CancerEndometrial Cancer+3 more
Herning Hospital
Early research (Phase 1)Looking for participantsNCT04038619
What this trial is testing

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Who this might be right for
ColitisDiarrheaMalignant Genitourinary System Neoplasm+6 more
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)WithdrawnNCT04102436
What this trial is testing

Non-Viral TCR Gene Therapy

Who this might be right for
Endocrine/NeuroendocrineNon-Small Cell Lung CancerBreast Cancer+2 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT02153801
What this trial is testing

Genito Urinary Function With High or Low Inferior Mesenteric Artery Ligation in Laparoscopic Anterior Rectal Resection

Who this might be right for
Genito Urinary Function Evaluation
Niguarda Hospital 212
Not applicableStudy completedNCT02222259
What this trial is testing

A Feasibility Trial of Geriatric Assessment and Management for Older Cancer Patients

Who this might be right for
Breast CancerGastrointestinal CancerGenitourinary Cancer
University of Toronto 60
Early research (Phase 1)Active Not RecruitingNCT02496208
What this trial is testing

Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors

Who this might be right for
Bladder Small Cell Neuroendocrine CarcinomaBladder Squamous Cell CarcinomaBladder Urothelial Carcinoma+27 more
National Cancer Institute (NCI) 152
Not applicableEnded earlyNCT02026960
What this trial is testing

RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)

Who this might be right for
Metastatic Renal Cell CarcinomaGenitourinary Cancer (Bladder, Prostate or Testicular)
Duke University 14
Very early researchStudy completedNCT04067960
What this trial is testing

Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+45 more
Mayo Clinic 197
Not applicableLooking for participantsNCT06464536
What this trial is testing

Evaluation of the Efficacy of Compression With Tight Surgical Gloves in Patients With Taxane-based Therapy

Who this might be right for
Taxane-induced Peripheral Neuropathy
St.Gallen University of Applied Sciences 114
Not applicableLooking for participantsNCT07215624
What this trial is testing

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study

Who this might be right for
Malignant Digestive System NeoplasmMalignant Female Reproductive System NeoplasmMalignant Genitourinary System Neoplasm
Wake Forest University Health Sciences 500
Early research (Phase 1)Active Not RecruitingNCT06253520
What this trial is testing

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

Who this might be right for
Metastatic Solid CancersColorectal CancerBreast Cancer+4 more
National Cancer Institute (NCI) 210
Next Page